| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |